Active ingredient

Terazosine.

Indications

Symptomatic treatment of benign prostatic hyperplasia.
Indicated in the treatment of essential, mild or moderate hypertension.

Presentations

ZAYASEL 5 mg, 28 tablets.
ZAYASEL 1 mg/ml, 150ml solution.

Dosage

For more information see the summary of product characteristics.

Summary of Product Characteristics (external link to the Spanish Drug Agency)

AEMPS